Sigma Ventures

Day-to-day investment decisions sit with General Partners Kshitij Naik, Nilyanka Bhushan, and Dr. Murali Murti. Naik handles deal origination and scaling, Bhushan manages LP relationships and consumer-tech theses, and Murti leads technology evaluation for defense, enterprise SaaS, and logistics. The firm also relies on Head of Investment Advisory Sunil Nair, who co-led over 40 private-equity transactions deploying more than $2 billion in equity at Citi Venture Capital International, though his exact voting or committee authority is not disclosed on the firm’s website.

Sigma’s sourcing model leans on a network of senior advisors with decades of operating and government experience. Dr. S. Narayan, former Economic Advisor to Prime Minister Atal Bihari Vajpayee, provides access to regulatory and policy circles, while Vice Admiral Suresh Bangara (Retd) opens defense-procurement channels. Thomas Preising and Arun Seth bring global tech supply-chain and telecom relationships from Apple and British Telecom. The firm’s website positions this advisor bench as its primary origination engine, supplementing the General Partners’ own networks across Indian and European emerging markets.

Sigma Ventures operates as a venture capital firm, not a family office. It raises external capital from limited partners — Nilyanka Bhushan explicitly leads LP relationships — and does not attribute its capital base to a single family fortune. The firm’s website refers to itself as a ‘Venture Capital fund’ and invites investors and entrepreneurs to partner with it, consistent with a traditional early-stage VC structure.

Sigma’s website positions the firm exclusively as a direct investor in early-stage startups, with no mention of fund-of-fund commitments, LP stakes in other managers, or secondaries. The team page ties each General Partner and advisor to specific sector and stage coverage for direct investments, without referencing any indirect investment programs.

The firm states it invests in ‘early-stage startups on the verge of explosive growth,’ specifying a focus on companies that demonstrate product-market fit, a talented founding team, and a scalable business model — traits more typical of seed to Series A stages. Its Altss research record also lists ‘Early Stage: Start-up’ and ‘Growth’ as strategy tags, indicating the firm may extend into select Series B or later rounds for existing portfolio companies.

Sigma does not publish a list of negative screens. However, its stated sector focus — FinTech, Health & Wellness, Consumer & Retail, Logistics & Transportation, Enterprise SaaS, and Defense & Aerospace — implicitly excludes areas such as heavy industry, mining, oil & gas, and biotech. The absence of any mention of life sciences or pharma in the team’s backgrounds or sector pages suggests those verticals are not part of the current mandate.

The firm’s website and team biographies do not disclose any affiliated philanthropic foundation, donor-advised fund, or impact-investing vehicle. While senior advisor Arun Seth individually mentions ‘giving back to society,’ there is no institutional separation between charitable activities and fund operations described in public materials.